What is Chartspan Medical Technologies?
Chartspan Medical Technologies operates as the premier provider of Chronic Care Management (CCM) services in the United States. The company distinguishes itself by offering a comprehensive suite of value-based care solutions designed to bridge the gap between clinical providers and patients managing long-term health conditions. Through a combination of advanced technology and clinical expertise, Chartspan enables healthcare organizations to improve patient outcomes while simultaneously driving operational efficiency. Their market position is defined by a commitment to scalable, patient-centric care models that align with the evolving requirements of the U.S. healthcare system, effectively reducing the burden on primary care providers while enhancing the quality of life for patients requiring consistent medical oversight.
How much funding has Chartspan Medical Technologies raised?
Chartspan Medical Technologies has raised a total of $88.6M across 8 funding rounds:
Angel/Seed
$1M
Private Equity
$1.7M
Private Equity
$3.2M
Private Equity
$16M
Series A
$15M
Debt
$1M
Stock/Share Issuance
$50.5M
Angel/Seed (2014): $1M led by Don Byrne
Private Equity (2015): $1.7M supported by Don Byrne
Private Equity (2016): $3.2M, investors not publicly disclosed
Private Equity (2017): $16M backed by Cypress Growth Capital
Series A (2019): $15M, investors not publicly disclosed
Debt (2020): $1M led by PPP
Stock/Share Issuance (2026): $50.5M, investors not publicly disclosed
Key Investors in Chartspan Medical Technologies
Cypress Growth Capital
Cypress Growth Capital specializes in providing royalty-based funding, offering flexible and non-dilutive growth capital tailored for emerging companies, particularly in the SaaS and tech-enabled services sectors. Their funding model allows businesses to retain equity while accessing necessary capital, with payments adjusting based on revenue performance.
Don Byrne
An individual investor who has demonstrated long-term commitment to the company's growth through multiple rounds of financing, ranging from early-stage seed capital to private equity support.
PPP
Public-Private Partnership
What's next for Chartspan Medical Technologies?
With the successful completion of this major enterprise-level funding round, Chartspan Medical Technologies is well-positioned to accelerate its national expansion and technological integration. The strategic deployment of this capital will likely focus on enhancing the company's digital health platform, expanding its clinical workforce, and deepening its penetration into value-based care markets. As the healthcare industry shifts toward outcome-oriented reimbursement models, Chartspan's ability to provide scalable, data-driven care management services will be critical. Investors and industry analysts will be monitoring the company's ability to maintain its growth trajectory while navigating the regulatory complexities inherent in the medical technology sector. The firm's focus remains on solidifying its leadership in the CCM space, potentially exploring new service lines that complement its existing value-based care offerings.
See full Chartspan Medical Technologies company page
